In vitro studies have implicated KRIT1/CCM1, a protein mutated in cerebral cavernous malformations (CCM), RASIP1 and an actin-cytoskeleton linker Canoe/Afadin as Rap1 effectors controlling cell-cell junction formation and maintenance. The gene discussed is RASIP1; the disease is cerebral cavernous malformation.